Evidence map›Paper›PMID 34350303›Full record

ReviewOrthopaedic journal of sports medicine2021

Osteoarthritis-Related Knee Pain Treated With Genicular Artery Embolization: A Systematic Review and Meta-analysis.

Pooya Torkian, Jafar Golzarian, Majid Chalian, Alexander Clayton, Shahram Rahimi-Dehgolan, Elnaz Tabibian, Reza Talaie

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Orthopaedic journal of sports medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07024654 (A Prospective Case Series), which is not on this map. Cited by 38 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 2 pooled it
9.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07024654 phase2withdrawnnot on this mapstarted 2026, after this paper: background citation

A Prospective Case Series: Genicular Embolization Using Doxycycline Sclerotherapy

TypeinterventionalSponsorCampbell ClinicRan2026 to 2029Enrolled0ConditionsChronic Knee Pain, OsteoarthritisArmsDoxycycline Injection
3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 2 syntheses or guidelines pooled it, 80 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Imipenem/Cilastatin in Embolization: From Antibiotic to Therapeutic Agent.Cardiovascular and interventional radiology · 2025
    Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Pooya TorkianDepartment of Radiology, Division of Vascular and Interventional Radiology, University of Minnesota, Minneapolis, USA.
Jafar GolzarianDepartment of Radiology, Division of Vascular and Interventional Radiology, University of Minnesota, Minneapolis, USA.
Majid ChalianDivision of Musculoskeletal Imaging and Intervention, Department of Radiology, University of Washington, Seattle, Washington, USA.
Alexander ClaytonDepartment of Radiology, Division of Vascular and Interventional Radiology, University of Minnesota, Minneapolis, USA.
Shahram Rahimi-DehgolanSchool of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Elnaz TabibianRadiology Department, Tehran University of Medical Sciences, Tehran, Iran.
Reza TalaieDepartment of Radiology, Division of Vascular and Interventional Radiology, University of Minnesota, Minneapolis, USA.
Shahid Beheshti University of Medical Sciences · IRTehran University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGenicular artery embolization (GAE) is an innovative technique that has been investigated as a supplementary treatment method for chronic pain secondary to knee osteoarthritis (OA). PURPOSE: To evaluate the current evidence on the effectiveness and safety of GAE for OA-related knee pain. STUDY

designSystematic review; Level of evidence, 4.

methodsA systematic literature search was conducted in the PubMed, Web of Science, EMBASE, and Scopus databases to identify studies related to knee OA treated with GAE. Treatment agents were categorized as Embozene, imipenem/cilastatin, resorbable microspheres, and polyvinyl alcohol. The main outcomes were the mean difference (MD) in pre- and postembolization pain based on the visual analog scale (VAS) or the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) scores as well as changes in the need for pain medication. Random- and fixed-effects models were applied for data analysis.

resultsOf 379 initially inspected publications, 11 (N = 225 patients; 268 knees) were included in the final review. The quality of the studies was fair in 8 and poor in 3-categorized according to the National Institutes of Health quality assessment tool. Overall, 119, 72, 13, and 21 patients were treated with imipenem/cilastatin, Embozene, resorbable microspheres, and polyvinyl alcohol, respectively. Symptomatic improvement was reported in all studies. The pooled effect size, characterized by MD, showed a significant improvement in the VAS and WOMAC pain scores, with better functional status after GAE. Pre- versus postembolization MDs in VAS scores ranged from 32 within the first week to 58 after a 2-year follow-up (equivalent to 54% and 80% improvement, respectively). There was a similar trend in the overall WOMAC scores, with MDs ranging from 28.4 to 36.8 (about 58% and 85% improvement, respectively). GAE resulted in a decreased need for pain medication for knee OA, with a 27%, 65%, and 73% decline in the number of patients who used opioids, nonsteroidal anti-inflammatory drugs, and intra-articular hyaluronic acid injection, respectively (

conclusionOA treated by GAE using different embolic particles can be considered generally safe, with good efficacy and no reported serious complications.

Indexed as

genicular artery embolizationknee jointknee painosteoarthritis

Identifiers

PMID34350303
PMCPMC8287378
OpenAlexW3183001230

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.